China/Asia Attendees
- 01Life Technology — CBO
- 4B Technologies — Global Head of Business Development
- 5Y Capital — Associate
- Affinity — CEO
- Alphamab Oncology — BD Director
- ApicHope Pharmaceutical — CSO
- ApicHope Pharmaceutical — BD Director
- Asahi Kasei Pharma Corporation — Manager
- Asymchem Zunji Capital — Senior Investment Manager
- Beijing Zhaode Investment Group — Investment Associate
- Binhui Pharma — Vice General Manager
- BioTrack Capital — Executive Director
- CMS Bio — Chief Business Officer
- CMS Group — VP
- Consun Pharmaceutical — Executive Director
- CSPC Pharma — CMO
- Daiichi Sankyo Co., Ltd. — Oncology Early-Stage Evaluation Lead
- DIAO — Senior Advisor / Clinical Development Lead
- E Fund Management — Analyst
- Ennova — CSO, Founder
- Excyte Biopharma — BD Director
- Excyte Biopharma — Chairman, Co-founder, COO
- Fast Track Initiative — Managing Partner
- Fuji Pharma Co. Ltd. — General Manager – Business Development
- Genesis Capital — Executive Director
- Genhouse — CNO
- Haisco Pharmaceutical — BD Director
- Haomai — Co-Founder and Executive President
- HEC —
- HK Inno.N — Head of K-CAB BD
- HK Inno.N — BD
- HK Inno.N — Vice President
- HK Inno.N — Analyst
- HK Inno.N — Manager
- Huilun Pharma —
- IASO Bio — BD
- Ieum value creator, Inc. — Principal Consultant
- Ildong Pharmaceutical — Business Development Manager
- Ildong Pharmaceutical Co.LTD — Head of BD&L, Managing Director
- Immunophage — CEO
- Joincare — VP
- Kaken Pharmaceutical — BD, Lead of Transactions
- Kaken Pharmaceutical Co., Ltd. — Manager, Business Development
- LeadingTac — CEO
- Leads Biolabs — Founder, Chairman, and CEO
- Maruho Co Ltd — Group Manager
- Novo Holdings (Asia) — Partner
- NRT — AD of BD
- Nuphase — CEO
- Oriza Seed — Investment Director
- Pin Therapeutics — Founder & CEO
- Pivotal bioVenture Partners — Director
- Qilu Pharmaceutical — BD Director
- Ranok Therapeutics — CFO
- Santen — US BD Manager
- Santen, Inc. — Director, Venture Management
- Shanghai Healthcare Capital — Senior Manager
- Shenzhen CrystalO Biopharma — VP, BD Head
- Sihuan Pharmaceutical — Deputy CEO/CFO, Executive Director
- Simcere Pharmaceuticals — SVP
- Sino Biopharma — BD Director
- SK Biopharmaceuticals — Director BD
- SPH Biotherapeutics (HK) Limited — VP and CSO
- Sungun — BD Director
- TransThera Sciences (Nanjing), Inc. — Chairman
- Ubix Therapeutics — Director of Business Development
- VelaVigo — CBO/CFO
- Viva BioInnovator — Chief Innovation Officer, Head of Investment
- VMS — Partner
- Wuhan YZY Biopharma Co., Ltd. — CEO
- Wuhan YZY Biopharma Co., Ltd. — BD Director
- Xuanzhu Biopharmaceutical — Senior Director of Business Development
- Yifan Pharmaceutical — BD Head
- Yonjin Venture — Investment Manager
- Youcare Pharmaceutical — BD Head
US/EU/Other Regions Attendees
- AbbVie — Director, BD & Acquisitions
- AbbVie — Global Head, Search & Evaluation Neuroscience
- AdBio partners — EiR
- Aditum Bio — Senior Associate
- Advantary Capital Partners — Partner
- Allander Biotechnologies — CEO
- Amplitude Ventures — Principal
- Apeximmune Therapeutics Inc. — CEO
- Arbor Biotechnologies — BD
- Architect Therapeutics / ARCH Venture — Corporate Development
- ArriVent Bio — BD Director
- Bain Capital — Vice President
- Bayer — Vice President and Head of Collaborate to Cure Hub China
- BioAge Labs — Director, Business Development
- Biobloc — CEO
- BioNTech — Senior Director of External Innovations
- Boehringer Ingelheim CHB — Head of Eye Health & Research Beyond Borders
- Boehringer Ingelheim International GmbH — Global Head of Neuroscience & Mental Health BD+L
- Bonum Therapeutics — VP Development
- Brii Biosciences — Sr Director, Business Development and Alliance Management
- Bristol Myers Squibb — Associate director, BD search & eval
- Chipscreen Biosciences (US) Ltd — GM
- ClearideBio Therapeutics — CEO & Co-Founder
- Crinetics Pharmaceuticals — Business Development Manager
- Cytokinetics — Senior Director Business Development
- Debiopharm — Head of Strategic Partnering
- Decheng Capital — Investor
- Deerfield Management — Investor
- Eisai Innovation — Managing Director of Investment
- Fairmount Funds — Operating Partner
- Forbion — Principal
- Forbion — Venture Partner
- Formation Bio — Senior Director
- Gilead Sciences — Senior Scientist
- Greywolf — CEO
- Greywolf — COO/CBO
- Helsinn — Chief Strategy Officer
- HUYABIO International — China Operations Manager
- IKSUDA Therapeutics — CBO
- Indaco Venture Partners — Partner biotech fund
- Insmed — VP, Head of BD
- Insmed — Associate Director BD
- Iterion Therapeutics — President & CEO
- Johnson & Johnson — Senior Director, Immunology External Innovation
- Johnson & Johnson — External Scientific Innovation, Transactions
- Johnson & Johnson — Head of External Scientific Innovation, Asia Pacific
- KDDF — Global Partnership & BD Director
- KPMG — SMD Tax
- Kymera Therapeutics — Director, Business Development
- Legend Biotech — Executive Director Business Development
- LIFTT — Venture Capital Manager
- LRI — VP
- LSVP — Head of Biotech
- Lumira Ventures — Partner
- LYFE Capital — Senior Associate
- LYFE Capital (US) — Partner
- LYFE Capital (US) — Director of Global Partnership
- Medicilon — Dir. BD
- Medicilon — VP of Global BD
- Medicilon — President
- Medicilon — Chief Business Officer
- Medicilon — Founder, Chairman, and CEO
- Medicilon — President of Drug Discovery and CMC Divisions
- MP Healthcare Venture Management — Director
- MP Healthcare Venture Management — President
- NiKang Therapeutics — President & CEO
- Normunity — Head of BD
- OrbiMed — Partner
- Pfizer — Global Development Lead
- RA Capital — Senior Research Assistant
- Regeneron — VP BD, Head of Immunology, Infectious Diseases and Metabolism Partnering
- Roche — Senior Manager Business Development
- Roche — Senior Manager Business Development
- Roche — Vice President, Head of Roche Pharma Partnering Asia
- Roche/Genentech — Global Search and Evaluation Lead
- RTW Investments — VP, New Ventures
- Salubris Biotherapeutics — CMO
- Salubris Biotherapeutics — Chief Executive Officer
- SaniMed Science Group — Founder & CEO
- Santen — Global Head Business Development
- Servier — Head of External Innovation
- Swedish Orphan Biovitrum (Sobi) — Strategy & Corporate Development
- Swedish Orphan Biovitrum (Sobi) — Head of Search and Evaluation
- SymBiosis Capital Management — Managing Partner
- Taiho Ventures — Partner
- The Venture Collective, LLC — Head of Life Science Investing
- Verdiva Bio — Chief Strategy Officer
- Vibrant Therapeutics — Head of BD
- Virion Therapeutics LLC — COO
BioToChina.org 